Unique ID issued by UMIN | UMIN000010734 |
---|---|
Receipt number | R000012546 |
Scientific Title | Can neuromuscular monitoring at the adductor pollicis detect timing for safe trachealintubation in elderly patients? |
Date of disclosure of the study information | 2013/05/16 |
Last modified on | 2014/10/04 20:24:42 |
Can neuromuscular monitoring at the adductor pollicis detect timing for safe trachealintubation in elderly patients?
The dose of rocuronium for safe tracheal intubation
Can neuromuscular monitoring at the adductor pollicis detect timing for safe trachealintubation in elderly patients?
The dose of rocuronium for safe tracheal intubation
Japan |
Surgical patients requiring general anesthesia
Anesthesiology |
Others
NO
For safe tracheal intubation, sufficient depth of neuromuscular block of the masseter, laryngeal muscles and diaphragm is needed. The responses of the adductor pollicis muscle (APM) to the ulnar nerve stimulation are usually observed during induction of anesthesia and used to determine the timing of tracheal intubation. However, movement of the vocal cord and cough reflex are frequently seen during laryngoscopy and tracheal intubation even after obtaining complete neuromuscular block at the APM.
We will examine a correlation between the dose of rocuronium and intubating conditions and hope to contribute to safe tracheal intubation in elderly patients.
Pharmacodynamics
onset time of rocuronium-induced neuromuscular block and evaluation of intubating conditions.
Interventional
Parallel
Randomized
Double blind -all involved are blinded
Dose comparison
2
Treatment
Medicine |
A correlation between onset of the action of rocuronium 0.6 mg/kg and intubating conditions will be analyzed.
A correlation between onset of the action of rocuronium 1mg/kg and intubating conditions will be analyzed.
65 | years-old | <= |
Not applicable |
Male and Female
1)Patients having allergic factors to neuromuscular blocking agents
2) ASA risk 4 and above
3) BMI 30 and above or below 18.5
4)Patients having hepatic and renal disorders
1)Patients having allergic factors to neuromuscular blocking agents
2)ASA risk 4 and above
3)BMI 30 and above or below 18.5
4)Patients having hepatic and renal disorders
40
1st name | |
Middle name | |
Last name | Satomi Yamamoto |
Nihon University of Medicine
Department of Anesthsiology
30-1 Oyaguchi-Kmimachi Itabashi-Ku Tokyo
1st name | |
Middle name | |
Last name |
Nihon University of Medicine
Department of Anesthsiology
30-1 Oyaguchi-Kmimachi Itabashi-Ku Tokyo
Nihon University of Medicine department of Anesthsiology
Nihon University of Medicine department of Anesthsiology
Other
NO
2013 | Year | 05 | Month | 16 | Day |
Unpublished
Completed
2013 | Year | 04 | Month | 05 | Day |
2013 | Year | 04 | Month | 05 | Day |
2013 | Year | 05 | Month | 16 | Day |
2014 | Year | 10 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012546